CCDC103: A Potential Drug Target in Multiple Diseases (G388389)

Target Name: CCDC103

NCBI ID: G388389

CCDC103

CCDC103: A Potential Drug Target in Multiple Diseases

CCDC103, also known as CC103_HUMAN, is a protein that is expressed in various tissues of the human body. It is a member of the CDK4 family, which is a group of transcription factors that play a crucial role in regulating gene expression.

One of the most interesting aspects of CCDC103 is its potential as a drug target. Its role in cell signaling and gene regulation makes it an attractive target for drug developers. Additionally, its expression is often regulated by key signaling pathways, which further increases its Potential as drug target.

CDK4 proteins have been identified as potential drug targets in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. CCDC103 is no exception. Its role in cell signaling and gene regulation makes it a promising target for drugs that can modulate its activity.

One of the key signaling pathways that CCDC103 is involved in is the TGF-β pathway. This pathway is involved in cell growth, differentiation, and survival, and is a key regulator of many diseases, including cancer. CCDC103 is a known co-factor of the TGF-β transcription factor, which activates its downstream targets, including the transcription factor PDGFR-尾.

Additionally, CCDC103 is also involved in the Wnt signaling pathway, which is involved in cell growth and development. CCDC103 has been shown to play a role in the regulation of Wnt signaling, and is a known co-factor of the transcription factor LWTX.

Another signaling pathway that CCDC103 is involved in is the PI3K/AKT signaling pathway. This pathway is involved in cell signaling and survival, and is a key regulator of many diseases, including cancer. CCDC103 is a known co-factor of the protein AKT1, which is a key regulator of the PI3K/AKT signaling pathway.

In addition to its role in cell signaling, CCDC103 is also a key regulator of gene expression. Its expression is regulated by key factors such as DNA methylation and histone modifications, which are important for the regulation of gene expression.

Given its involvement in multiple signaling pathways and its potential as a drug target, CCDC103 is an attractive target for drug developers. But it should also be noted that its expression is regulated by multiple factors, including its expression in various tissues and its role in cell signaling. This makes it difficult to predict the effects of a potential drug treatment.

In conclusion, CCDC103 is a protein that is expressed in various tissues of the human body and is involved in multiple signaling pathways. Its potential as a drug target and its involvement in cell signaling make it an attractive target for drug developers. Further research is needed to fully understand its role in disease and to develop effective treatments.

Protein Name: Coiled-coil Domain Containing 103

Functions: Dynein-attachment factor required for cilia motility

The "CCDC103 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC103 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets